151 related articles for article (PubMed ID: 30699313)
1. CD47 Blockade and Rituximab in Non-Hodgkin's Lymphoma.
Advani R; Volkmer JP; Chao MP
N Engl J Med; 2019 Jan; 380(5):497-498. PubMed ID: 30699313
[No Abstract] [Full Text] [Related]
2. CD47 Blockade and Rituximab in Non-Hodgkin’s Lymphoma.
Li Y
N Engl J Med; 2019 Jan; 380(5):497. PubMed ID: 30702241
[No Abstract] [Full Text] [Related]
3. CD47 Blockade and Rituximab in Non-Hodgkin’s Lymphoma.
Valerius T; Rösner T; Leusen JHW
N Engl J Med; 2019 Jan; 380(5):496-7. PubMed ID: 30702240
[No Abstract] [Full Text] [Related]
4. CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin's Lymphoma.
Advani R; Flinn I; Popplewell L; Forero A; Bartlett NL; Ghosh N; Kline J; Roschewski M; LaCasce A; Collins GP; Tran T; Lynn J; Chen JY; Volkmer JP; Agoram B; Huang J; Majeti R; Weissman IL; Takimoto CH; Chao MP; Smith SM
N Engl J Med; 2018 Nov; 379(18):1711-1721. PubMed ID: 30380386
[TBL] [Abstract][Full Text] [Related]
5. Rituximab for aggressive non-Hodgkin's lymphomas relapsing after or refractory to autologous stem cell transplantation.
Pan D; Moskowitz CH; Zelenetz AD; Straus D; Kewalaramani T; Noy A; Qin J; Teruya-Feldstein J; Portlock CS
Cancer J; 2002; 8(5):371-6. PubMed ID: 12416894
[TBL] [Abstract][Full Text] [Related]
6. Rituximab as first-line and maintenance therapy for patients with indolent non-Hodgkin's lymphoma: interim follow-up of a multicenter phase II trial.
Hainsworth JD
Semin Oncol; 2002 Feb; 29(1 Suppl 2):25-9. PubMed ID: 11842385
[TBL] [Abstract][Full Text] [Related]
7. Hodgkin's and non-Hodgkin's lymphomas.
Rademaker J
Radiol Clin North Am; 2007 Jan; 45(1):69-83. PubMed ID: 17157624
[TBL] [Abstract][Full Text] [Related]
8. Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPP
Borchmann P; Haverkamp H; Lohri A; Mey U; Kreissl S; Greil R; Markova J; Feuring-Buske M; Meissner J; Dührsen U; Ostermann H; Keller U; Maschmeyer G; Kuhnert G; Dietlein M; Kobe C; Eich H; Baues C; Stein H; Fuchs M; Diehl V; Engert A
Lancet Oncol; 2017 Apr; 18(4):454-463. PubMed ID: 28236583
[TBL] [Abstract][Full Text] [Related]
9. B cell non-Hodgkin's lymphoma: rituximab safety experience.
Mohrbacher A
Arthritis Res Ther; 2005; 7 Suppl 3(Suppl 3):S19-25. PubMed ID: 15960818
[TBL] [Abstract][Full Text] [Related]
10. Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma.
Chao MP; Alizadeh AA; Tang C; Myklebust JH; Varghese B; Gill S; Jan M; Cha AC; Chan CK; Tan BT; Park CY; Zhao F; Kohrt HE; Malumbres R; Briones J; Gascoyne RD; Lossos IS; Levy R; Weissman IL; Majeti R
Cell; 2010 Sep; 142(5):699-713. PubMed ID: 20813259
[TBL] [Abstract][Full Text] [Related]
11. Non-Hodgkin's lymphoma in systemic sclerosis: case and literature review.
Vettori S; Staibano S; Mascolo M; Ilardi G; Valentini G
Clin Rheumatol; 2010 Jan; 29(1):1-6. PubMed ID: 19809778
[TBL] [Abstract][Full Text] [Related]
12. Peri-infusional adverse reactions to rituximab in patients with non-Hodgkin's lymphoma.
Arredondo-Garza T; Majluf-Cruz A; Vela-Ojeda J; Mariscal-Ramírez I; Solis-Anaya L; Lopez-Gutiérrez JR; Guadarrama CH; Rico-Curiel E; Armenta-San Sebastián JA; Castañeda-Hernández G
Arch Med Res; 2013 Oct; 44(7):549-54. PubMed ID: 24120421
[TBL] [Abstract][Full Text] [Related]
13. A pioneer experience in Malaysia on In-house Radio-labelling of (131)I-rituximab in the treatment of Non-Hodgkin's Lymphoma and a case report of high dose (131)I-rituximab-BEAM conditioning autologous transplant.
Kuan JW; Law CS; Wong XQ; Ko CT; Awang ZH; Chew LP; Chang KM
Appl Radiat Isot; 2016 Oct; 116():13-21. PubMed ID: 27472826
[TBL] [Abstract][Full Text] [Related]
14. Rituximab immunotherapy for non-Hodgkin's lymphoma.
White CA
Cancer Biother Radiopharm; 1999 Aug; 14(4):241-50. PubMed ID: 10850310
[TBL] [Abstract][Full Text] [Related]
15. Rituximab Faster Infusion for Patients With Non-Hodgkin's Lymphoma in the United States: Implications for Nursing Practice.
Dawson K
J Infus Nurs; 2015; 38 Suppl 6():S4-S10. PubMed ID: 26536411
[TBL] [Abstract][Full Text] [Related]
16. A possible coincidence of cytomegalovirus retinitis and intraocular lymphoma in a patient with systemic non-Hodgkin's lymphoma.
Svozílková P; Heissigerová J; Brichová M; Kalvodová B; Dvořák J; Ríhová E
Virol J; 2013 Jan; 10():18. PubMed ID: 23295015
[TBL] [Abstract][Full Text] [Related]
17. [Monoclonal antibody therapy for non-Hodgkin's lymphoma].
Paul F; Rossi JF; Cartron G
Rev Prat; 2010 Jan; 60(1):59-63. PubMed ID: 20222313
[TBL] [Abstract][Full Text] [Related]
18. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
19. Rituximab: review and clinical applications focusing on non-Hodgkin's lymphoma.
King KM; Younes A
Expert Rev Anticancer Ther; 2001 Aug; 1(2):177-86. PubMed ID: 12113023
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and preliminary evaluation of
Suman SK; Kameswaran M; Mallia M; Mittal S; Dash A
Appl Radiat Isot; 2019 Nov; 153():108808. PubMed ID: 31325798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]